RT Journal Article
SR Electronic
T1 Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008547
DO 10.1136/jitc-2023-008547
VO 12
IS 4
A1 Odegard, Jared M
A1 Othman, Ahmed A
A1 Lin, Kai-Wen
A1 Wang, Adele Y
A1 Nazareno, Jonathan
A1 Yoon, Oh Kyu
A1 Ling, John
A1 Lad, Latesh
A1 Dunbar, P Rod
A1 Thai, Dung
A1 Ang, Edmond
A1 Waldron, Nicholas
A1 Deva, Sanjeev
YR 2024
UL http://jitc.bmj.com/content/12/4/e008547.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.